Pediatrics Doctors in Alexandria, MN Accepting Medicare

5 Pediatrics doctors found. Showing 1 - 5

Justin T Conley, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 610 30th Ave W, Alexandria, MN 56308 Phone: 320-763-5123    Fax: 320-763-7883

Brian D Carlsen, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 610 30th Avenue West, Alexandria Clinic, Alexandria, MN 56308 Phone: 320-763-5123    Fax: 320-763-7883

Jean K Fahey, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 610 30th Avenue West, Alexandria Clinic Pa, Alexandria, MN 56308 Phone: 320-763-5123    Fax: 320-763-7883

Marcine P Ellwein, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 610 30th Ave W, Alexandria, MN 56308 Phone: 320-763-5123    Fax: 320-763-7883

Kenneth J. Martin, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 610 30th Ave W, Alexandria, MN 56308 Phone: 320-763-5123    Fax: 320-763-7883

News Archive

Court hearing to allow Luna Innovations to emerge from bankruptcy set for January 12

Luna Innovations Incorporated announced today that a bankruptcy court hearing has been set for January 12, 2010, to decide whether to confirm Luna's Plan of Reorganization and allow Luna to emerge from bankruptcy.

Study compares treatment cost of PID hospitalizations, ER care for teen girls

Hospitalizing teen girls with pelvic inflammatory disease costs six times as much as treating them in the emergency room, and up to 12 times more than treating them in an outpatient clinic, according to a small study conducted at the Johns Hopkins Children's Center.

GAO finds big disparities in prices of some medical devices

News outlets examine a variety of health workplace issues, including a GAO report on medical device prices and efforts to get health workers vaccinated for the flu.

Sanofi-aventis reports new 1-year data from teriflunomide Phase II study for relapsing multiple sclerosis

Sanofi-aventis reported today new one-year data from a Phase II study with teriflunomide, a novel oral disease modifier being investigated for the treatment of relapsing multiple sclerosis (RMS). Study results demonstrated an improvement in outcomes, with a consistent safety profile with the data from a previous Phase II monotherapy study, in patients treated with interferon beta (IFN-[BETA]) - a standard therapy in RMS - and receiving teriflunomide 7mg or 14mg, compared with patients treated with IFN-[BETA] and receiving oral placebo.

Women have poorer short-term recovery than men from arthroscopic knee surgery

The factors associated with poor short-term recovery from knee surgery appear to be different than those found to mar long-term outcome from the same surgery, according to new research released at the 2007 Annual Meeting of the American Orthopaedic Society for Sports Medicine at the Telus Convention Center.

Read more Medical News

› Verified 5 days ago